HK1201264A1 - Long-acting injectable moxikine formulation and new moxidectin crystal form - Google Patents
Long-acting injectable moxikine formulation and new moxidectin crystal formInfo
- Publication number
- HK1201264A1 HK1201264A1 HK15101758.3A HK15101758A HK1201264A1 HK 1201264 A1 HK1201264 A1 HK 1201264A1 HK 15101758 A HK15101758 A HK 15101758A HK 1201264 A1 HK1201264 A1 HK 1201264A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- moxidectin
- amorphous
- crystals
- dried
- dsc
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/22—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161566336P | 2011-12-02 | 2011-12-02 | |
| US61/566,336 | 2011-12-02 | ||
| PCT/US2012/067215 WO2013082373A1 (en) | 2011-12-02 | 2012-11-30 | Long-acting injectable moxidectin formulations and novel moxidectin crystal forms |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HK1201264A1 true HK1201264A1 (en) | 2015-08-28 |
| HK1201264B HK1201264B (en) | 2018-07-20 |
Family
ID=
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2785719B1 (en) | Long-acting injectable moxidectin formulations and novel moxidectin crystal forms | |
| AU2018205137B2 (en) | Long-acting injectable formulations comprising an isoxazoline active agent, methods and uses thereof | |
| JP5132560B2 (ja) | 長期作用型注射用製剤 | |
| GB2514951B (en) | Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof | |
| AU2016246598B2 (en) | Extended release injectable formulations comprising an isoxazoline active agent, methods and uses thereof | |
| EP2890699A1 (en) | Crystalline forms of 1-(5'-(5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)-3'h-spiro[azetidine-3,1'-isobenzofuran]-1-yl)-2-(methylsulfonyl)ethanone | |
| PL176733B1 (pl) | Nowe czynniki przeciwpasożytnicze pokrewne milbemycynom i awermektynom | |
| EP2892902A1 (en) | Spirocyclic derivatives as antiparasitic agents | |
| RU2747149C9 (ru) | Анти-эндопаразитарные депсипептиды | |
| EP2855457A1 (en) | Azetidine derivatives as antiparasitic agents | |
| HK1201264B (en) | Long-acting injectable moxidectin formulations and novel moxidectin crystal forms | |
| AU2019266197B2 (en) | Endoparasitic depsipeptides | |
| NO300136B1 (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive, stabile salter av 4''-deoksy-4''-epi-metylaminoavermectin B1a/B1b | |
| OA17075A (en) | Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof. |